CRVO
CervoMed·NASDAQ
--
--(--)
--
--(--)
7.21 / 10
Outperform
Analyst sentiment is overwhelmingly positive (Strong Buy 75%, Buy 25%) with robust fund inflows—scored 7.75/10—though overall fund-flow trends are negative. This divergence suggests institutional interest despite short-term price weakness, and the analyst consensus provides a bullish counterweight to the neutral technicals.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
75%
Buy
25%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-05
InstitutionD. Boral Capital
Times predicted14
Historical Win Rate71.4%
What is the analyst consensus for CRVO?
- CRVO holds a Bullish analyst rating, with 75% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.21/10 (Outperform).
